4KFJ

Human dihydrofolate reductase complexed with NADPH and 5-{3-[3-methoxy-5-(isoquin-5-yl)phenyl]prop-1-yn-1-yl}6-ethylprimidine-2,4-diamine

Summary for 4KFJ

Entry DOI	10.2210/pdb4kfj/pdb
Related	4KAK 4KBN 4KD7 4KEB
Descriptor	Dihydrofolate reductase, NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, 6-ethyl-5-{3-[3-(isoquinolin-5-yl)-5-methoxyphenyl]prop-1-yn-1-yl}pyrimidine-2,4-diamine, ... (8 entities in total)
Functional Keywords	oxidoreductase, 5, 6, 7, 8-tetrahydrofolate; nadp+, hydride shift, cytosol, oxidoreductase-oxidoreductase inhibitor complex, oxidoreductase/oxidoreductase inhibitor
Biological source	Homo sapiens (Human)
Total number of polymer chains	2
Total formula weight	45279.27
Authors	Lamb, K.M.,Anderson, A.C. (deposition date: 2013-04-26, release date: 2013-10-09, Last modification date: 2023-09-20)
Primary citation	Lamb, K.M.,G-Dayanandan, N.,Wright, D.L.,Anderson, A.C. Elucidating features that drive the design of selective antifolates using crystal structures of human dihydrofolate reductase. Biochemistry, 52:7318-7326, 2013 Cited by PubMed: 24053334 DOI: 10.1021/bi400852h PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (1.76 Å)

Structure validation